Depressor effect of chymase inhibitor in mice with high salt-induced moderate hypertension

Am J Physiol Heart Circ Physiol. 2015 Dec 1;309(11):H1987-96. doi: 10.1152/ajpheart.00721.2014. Epub 2015 Oct 2.

Abstract

The aim of the present study was to determine whether long-term high salt intake in the drinking water induces hypertension in wild-type (WT) mice and whether a chymase inhibitor or other antihypertensive drugs could reverse the increase of blood pressure. Eight-week-old male WT mice were supplied with drinking water containing 2% salt for 12 wk (high-salt group) or high-salt drinking water plus an oral chymase inhibitor (TPC-806) at four different doses (25, 50, 75, or 100 mg/kg), captopril (75 mg/kg), losartan (100 mg/kg), hydrochlorothiazide (3 mg/kg), eplerenone (200 mg/kg), or amlodipine (6 mg/kg). Control groups were given normal water with or without the chymase inhibitor. Blood pressure and heart rate gradually showed a significant increase in the high-salt group, whereas a dose-dependent depressor effect of the chymase inhibitor was observed. There was also partial improvement of hypertension in the losartan- and eplerenone-treated groups but not in the captopril-, hydrochlorothiazide-, and amlodipine-treated groups. A high salt load significantly increased chymase-dependent ANG II-forming activity in the alimentary tract. In addition, the relative contribution of chymase to ANG II formation, but not actual average activity, showed a significant increase in skin and skeletal muscle, whereas angiotensin-converting enzyme-dependent ANG II-forming activity and its relative contribution were reduced by high salt intake. Plasma and urinary renin-angiotensin system components were significantly increased in the high-salt group but were significantly suppressed in the chymase inhibitor-treated group. In conclusion, 2% salt water drinking for 12 wk caused moderate hypertension and activated the renin-angiotensin system in WT mice. A chymase inhibitor suppressed both the elevation of blood pressure and heart rate, indicating a definite involvement of chymase in salt-sensitive hypertension.

Keywords: chymase inhibitor; high salt; hypertension; mouse; renin-angiotensin system.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Albuminuria / enzymology
  • Albuminuria / prevention & control
  • Aldosterone / blood
  • Aldosterone / urine
  • Angiotensin II / blood
  • Angiotensin II Type 1 Receptor Blockers / pharmacology
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Angiotensinogen / urine
  • Animals
  • Antihypertensive Agents / pharmacology*
  • Blood Pressure / drug effects*
  • Calcium Channel Blockers / pharmacology
  • Chymases / antagonists & inhibitors*
  • Chymases / metabolism
  • Disease Models, Animal
  • Diuretics / pharmacology
  • Heart Rate / drug effects
  • Hypertension / drug therapy*
  • Hypertension / enzymology
  • Hypertension / physiopathology
  • Male
  • Mice, Inbred C57BL
  • Mineralocorticoid Receptor Antagonists / pharmacology
  • Renin-Angiotensin System / drug effects
  • Serine Proteinase Inhibitors / pharmacology*
  • Sodium Chloride, Dietary*
  • Time Factors

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Calcium Channel Blockers
  • Diuretics
  • Mineralocorticoid Receptor Antagonists
  • Serine Proteinase Inhibitors
  • Sodium Chloride, Dietary
  • Angiotensinogen
  • Angiotensin II
  • Aldosterone
  • Chymases